First Eagle Investment Management
HAE icon

First Eagle Investment Management’s Haemonetics HAE Stock Holding History

First Eagle Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,000
Closed -$326K – 355
2014
Q1 		$326K Hold
10,000
– – ﹤0.01% 272
2013
Q4 		$421K Buy
10,000
+1,000
+11% +$41.2K ﹤0.01% 258
2013
Q3 		$359K Hold
9,000
– – ﹤0.01% 249
2013
Q2 		$372K Buy
+9,000
New +$364K ﹤0.01% 275

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

First Eagle Investment Management's HAE Position: Q2 2014 in Review

First Eagle Investment Management sold out of Haemonetics (HAE) in Q2 2014, closing a stake of 10,000 shares — an estimated $326K sold.

First Eagle Investment Management first reported a position in HAE in Q2 2013 and held it in 4 quarters. The position peaked at $421K in Q4 2013. 175 funds tracked by Wall St. Rank hold HAE as of Q2 2014.

  • First Eagle Investment Management reported no remaining Haemonetics position as of Q2 2014 after selling out during the quarter.
  • First Eagle Investment Management sold 10,000 Haemonetics shares in Q2 2014, an estimated $326K.
  • First Eagle Investment Management first reported a position in Haemonetics in Q2 2013 and held it in 4 quarters.
  • First Eagle Investment Management's Haemonetics position peaked at $421K in Q4 2013.
  • 175 funds tracked by Wall St. Rank held Haemonetics as of Q2 2014.

Based on First Eagle Investment Management's 13F filing for Q2 2014, filed 8 Aug 2014.